The microarray scanners market size has grown strongly in recent years. It will grow from $0.94 billion in 2024 to $1.01 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increased genomic research, pharmaceutical industry growth, academic and research institutes, diagnostic applications, high-throughput screening.
The microarray scanners market size is expected to see strong growth in the next few years. It will grow to $1.38 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to growing focus on pharmacogenomics, increasing demand for biobanking, increased focus on infectious disease research, increasing demand for diagnostic laboratories, growing application areas of microarrays. Major trends in the forecast period include focus on cancer research, technological innovation, and strategic partnerships.
The anticipated growth in the microarray scanner market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting three months or more and having the potential to worsen over time, can be effectively studied using microarray scanners. These devices enable the assessment of gene expression patterns, allowing researchers to delve into the molecular mechanisms underlying chronic diseases and identify potential biomarkers for diagnosis, prognosis, and treatment. According to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, the global population with chronic diseases is projected to reach 142.66 million by 2050, a significant increase from 71.522 million in 2020. Thus, the growing prevalence of chronic diseases is a key driver for the expansion of the microarray scanner market.
The rising health expenditure is anticipated to drive the growth of the microarray scanners market in the coming years. Health expenditure refers to the total amount of public and private resources allocated to health-related products and services over a specific period, typically assessed annually. Increased spending on health enhances the expansion and refinement of genomics research, leading to advancements in healthcare and personalized therapies. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure in the UK rose by 5.6% in nominal terms in 2023, reaching approximately £292 billion. Government-financed healthcare expenditure also increased to around £239 billion. As a result, the growing health expenditure is expected to positively impact the microarray scanner market.
Product innovations are a significant trend gaining traction in the microarray scanners market. Leading companies in this sector are focusing on developing cutting-edge products to maintain their competitive edge. For example, in June 2023, MARGenomics, a Spain-based company, launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform representing a major advancement in microarray technology. This platform is notable for being the first in Europe and the United States to receive regulatory approval for diagnostic purposes, highlighting its potential impact on clinical diagnostics and research. With its capability to deliver high-resolution genomic data, it is set to enhance personalized medicine approaches across various therapeutic areas.
Major players in the microarray scanner market are directing their focus on product innovations, specifically in the development of chromosomal microarray scanners, to better cater to the needs of their existing customer base. Chromosomal microarray scanners are sophisticated laboratory instruments designed for high-throughput DNA sample analysis, with a specific emphasis on detecting chromosomal abnormalities. For example, in August 2023, Thermo Fisher Scientific Inc., a US-based manufacturer of microarray scanners and other analytical instruments, launched the Applied Biosystems CytoScan HD Accel array. This array offers the industry's fastest chromosomal microarray analytical methodology and enhanced coverage, scanning the entire human genome and providing increased coverage in over 5,000 crucial genomic areas. The Applied Biosystems CytoScan HD Accel array contributes valuable insights into chromosomal variations applicable to a wide range of prenatal, postnatal, and cancer research applications.
In January 2022, Illumina Inc., a US-based biotechnology company specializing in microarray scanners, entered into a collaboration with SomaLogic, a US-based clinical diagnostics company. This collaboration aims to expedite next-generation sequencing into Proteomics and initiate a multi-year development effort to integrate SomaLogic's protein target volume with Illumina's sequencing technologies, creating a comprehensive end-to-end NGS workflow solution.
Major companies operating in the microarray scanners market include F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE Healthcare Life Sciences, Hitachi High-Tech Corporation, Innopsys Inc., PerkinElmer Inc., VWR International LLC, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Tecan Group AG, Huron Technologies International Inc., Miltenyi Biotec B.V. & Co. KG, GVS S.p.A., Luminex Corporation, Molecular Devices LLC, CapitalBio Technology Inc., Berthold Technologies GmbH & Co. KG, RayBiotech Inc., Scienion AG, Oxford Gene Technology IP Limited, Applied Microarrays Inc., Arrayit Corporation, Meridian Bioscience Inc., Montreal Biotech Inc.
North America was the largest region in the microarray scanners market in 2024. The regions covered in the microarray scanners market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microarray scanners market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Microarray scanners play a crucial role in molecular biology and genetics research, specifically for the analysis of microarrays. Microarrays are arrays of microscopic spots containing immobilized DNA, RNA, proteins, or other molecules on solid surfaces such as glass slides or silicon chips. These scanners are utilized to measure the fluorescent regions of DNA microarrays, providing detailed insights into the simultaneous activity of numerous genes.
The primary product categories of microarray scanners include fluorescence microarray scanners, charge-coupled device microarray scanners, colorimetric microarray scanners, and others. Fluorescence microarray scanners are specialized instruments designed for the detection and capture of fluorescent signals emitted by molecules labeled with fluorescence on microarrays. Microarray scanners utilize various technologies, including slide-based and gel-based approaches, with applications spanning gene expression, drug discovery, and more. The end users of these scanners are diverse and include hospitals, diagnostic laboratories, pharmaceutical and biotechnology companies, as well as academic and research institutes.
The microarray scanners market research report is one of a series of new reports that provides microarray scanners market statistics, including microarray scanners industry global market size, regional shares, competitors with a microarray scanners market share, detailed microarray scanners market segments, market trends and opportunities, and any further data you may need to thrive in the microarray scanners industry. This microarray scanner market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The microarray scanners market consists of sales of microarray slides, microarray printing and labeling kit, microarray scanners software and analysis tools, and microarray wash stations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The microarray scanners market size is expected to see strong growth in the next few years. It will grow to $1.38 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to growing focus on pharmacogenomics, increasing demand for biobanking, increased focus on infectious disease research, increasing demand for diagnostic laboratories, growing application areas of microarrays. Major trends in the forecast period include focus on cancer research, technological innovation, and strategic partnerships.
The anticipated growth in the microarray scanner market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting three months or more and having the potential to worsen over time, can be effectively studied using microarray scanners. These devices enable the assessment of gene expression patterns, allowing researchers to delve into the molecular mechanisms underlying chronic diseases and identify potential biomarkers for diagnosis, prognosis, and treatment. According to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, the global population with chronic diseases is projected to reach 142.66 million by 2050, a significant increase from 71.522 million in 2020. Thus, the growing prevalence of chronic diseases is a key driver for the expansion of the microarray scanner market.
The rising health expenditure is anticipated to drive the growth of the microarray scanners market in the coming years. Health expenditure refers to the total amount of public and private resources allocated to health-related products and services over a specific period, typically assessed annually. Increased spending on health enhances the expansion and refinement of genomics research, leading to advancements in healthcare and personalized therapies. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure in the UK rose by 5.6% in nominal terms in 2023, reaching approximately £292 billion. Government-financed healthcare expenditure also increased to around £239 billion. As a result, the growing health expenditure is expected to positively impact the microarray scanner market.
Product innovations are a significant trend gaining traction in the microarray scanners market. Leading companies in this sector are focusing on developing cutting-edge products to maintain their competitive edge. For example, in June 2023, MARGenomics, a Spain-based company, launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform representing a major advancement in microarray technology. This platform is notable for being the first in Europe and the United States to receive regulatory approval for diagnostic purposes, highlighting its potential impact on clinical diagnostics and research. With its capability to deliver high-resolution genomic data, it is set to enhance personalized medicine approaches across various therapeutic areas.
Major players in the microarray scanner market are directing their focus on product innovations, specifically in the development of chromosomal microarray scanners, to better cater to the needs of their existing customer base. Chromosomal microarray scanners are sophisticated laboratory instruments designed for high-throughput DNA sample analysis, with a specific emphasis on detecting chromosomal abnormalities. For example, in August 2023, Thermo Fisher Scientific Inc., a US-based manufacturer of microarray scanners and other analytical instruments, launched the Applied Biosystems CytoScan HD Accel array. This array offers the industry's fastest chromosomal microarray analytical methodology and enhanced coverage, scanning the entire human genome and providing increased coverage in over 5,000 crucial genomic areas. The Applied Biosystems CytoScan HD Accel array contributes valuable insights into chromosomal variations applicable to a wide range of prenatal, postnatal, and cancer research applications.
In January 2022, Illumina Inc., a US-based biotechnology company specializing in microarray scanners, entered into a collaboration with SomaLogic, a US-based clinical diagnostics company. This collaboration aims to expedite next-generation sequencing into Proteomics and initiate a multi-year development effort to integrate SomaLogic's protein target volume with Illumina's sequencing technologies, creating a comprehensive end-to-end NGS workflow solution.
Major companies operating in the microarray scanners market include F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE Healthcare Life Sciences, Hitachi High-Tech Corporation, Innopsys Inc., PerkinElmer Inc., VWR International LLC, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Tecan Group AG, Huron Technologies International Inc., Miltenyi Biotec B.V. & Co. KG, GVS S.p.A., Luminex Corporation, Molecular Devices LLC, CapitalBio Technology Inc., Berthold Technologies GmbH & Co. KG, RayBiotech Inc., Scienion AG, Oxford Gene Technology IP Limited, Applied Microarrays Inc., Arrayit Corporation, Meridian Bioscience Inc., Montreal Biotech Inc.
North America was the largest region in the microarray scanners market in 2024. The regions covered in the microarray scanners market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microarray scanners market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Microarray scanners play a crucial role in molecular biology and genetics research, specifically for the analysis of microarrays. Microarrays are arrays of microscopic spots containing immobilized DNA, RNA, proteins, or other molecules on solid surfaces such as glass slides or silicon chips. These scanners are utilized to measure the fluorescent regions of DNA microarrays, providing detailed insights into the simultaneous activity of numerous genes.
The primary product categories of microarray scanners include fluorescence microarray scanners, charge-coupled device microarray scanners, colorimetric microarray scanners, and others. Fluorescence microarray scanners are specialized instruments designed for the detection and capture of fluorescent signals emitted by molecules labeled with fluorescence on microarrays. Microarray scanners utilize various technologies, including slide-based and gel-based approaches, with applications spanning gene expression, drug discovery, and more. The end users of these scanners are diverse and include hospitals, diagnostic laboratories, pharmaceutical and biotechnology companies, as well as academic and research institutes.
The microarray scanners market research report is one of a series of new reports that provides microarray scanners market statistics, including microarray scanners industry global market size, regional shares, competitors with a microarray scanners market share, detailed microarray scanners market segments, market trends and opportunities, and any further data you may need to thrive in the microarray scanners industry. This microarray scanner market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The microarray scanners market consists of sales of microarray slides, microarray printing and labeling kit, microarray scanners software and analysis tools, and microarray wash stations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Microarray Scanners Market Characteristics3. Microarray Scanners Market Trends and Strategies4. Microarray Scanners Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Microarray Scanners Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Microarray Scanners Market34. Recent Developments in the Microarray Scanners Market
5. Global Microarray Scanners Growth Analysis and Strategic Analysis Framework
6. Microarray Scanners Market Segmentation
7. Microarray Scanners Market Regional and Country Analysis
8. Asia-Pacific Microarray Scanners Market
9. China Microarray Scanners Market
10. India Microarray Scanners Market
11. Japan Microarray Scanners Market
12. Australia Microarray Scanners Market
13. Indonesia Microarray Scanners Market
14. South Korea Microarray Scanners Market
15. Western Europe Microarray Scanners Market
16. UK Microarray Scanners Market
17. Germany Microarray Scanners Market
18. France Microarray Scanners Market
19. Italy Microarray Scanners Market
20. Spain Microarray Scanners Market
21. Eastern Europe Microarray Scanners Market
22. Russia Microarray Scanners Market
23. North America Microarray Scanners Market
24. USA Microarray Scanners Market
25. Canada Microarray Scanners Market
26. South America Microarray Scanners Market
27. Brazil Microarray Scanners Market
28. Middle East Microarray Scanners Market
29. Africa Microarray Scanners Market
30. Microarray Scanners Market Competitive Landscape and Company Profiles
31. Microarray Scanners Market Other Major and Innovative Companies
35. Microarray Scanners Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Microarray Scanners Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on microarray scanners market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for microarray scanners? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microarray scanners market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product Type: Fluorescence Microarray Scanners; Charge-Coupled Devices Microarray Scanners; Colorimetric Microarray Scanners; Other Product Types2) By Technology: Slide-based; Gel-based
3) By Application: Gene Expression; Drug Discovery; Other Applications
4) By End User: Hospitals; Diagnostic Laboratories; Pharmaceutical and Biotechnology Companies; Academic and Research Institutes
Subsegments:
1) By Fluorescence Microarray Scanners: Laser Scanners; Multispectral Scanners2) By Charge-Coupled Devices (CCD) Microarray Scanners: Standard CCD Scanners; High-Resolution CCD Scanners
3) By Colorimetric Microarray Scanners: Slide Scanners; Digital Colorimetric Scanners
4) By Other Product Types: Hybrid Scanners; Custom or Specialized Microarray Scanners
Key Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; GE Healthcare Life Sciences; Hitachi High-Tech Corporation; Innopsys Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- GE Healthcare Life Sciences
- Hitachi High-Tech Corporation
- Innopsys Inc.
- PerkinElmer Inc.
- VWR International LLC
- Illumina Inc.
- Bio-Rad Laboratories Inc.
- Agilent Technologies Inc.
- Tecan Group AG
- Huron Technologies International Inc.
- Miltenyi Biotec B.V. & Co. KG
- GVS S.p.A.
- Luminex Corporation
- Molecular Devices LLC
- CapitalBio Technology Inc.
- Berthold Technologies GmbH & Co. KG
- RayBiotech Inc.
- Scienion AG
- Oxford Gene Technology IP Limited
- Applied Microarrays Inc.
- Arrayit Corporation
- Meridian Bioscience Inc.
- Montreal Biotech Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 1.01 Billion |
| Forecasted Market Value ( USD | $ 1.38 Billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
